Precancerous Breast Changes in Women with BRCA Gene Identified Using MR Spectroscopy
By MedImaging International staff writers Posted on 09 Mar 2015 |
A Magnetic Resonance Spectroscopy (MRS) technique found multiple distinct premalignant changes in the biochemistry of breast tissue of women at high risk of breast cancer. The same changes were not recorded by conventional contrast-enhanced imaging 3-T Magnetic Resonance Imaging (MRI), and Ultrasound.
The discovery was made in a study carried out by a multidisciplinary team, including radiologists, radiographers, an MR physicist, and chemists. The study was published online in the March issue of the journal Radiology.
The study compared 14 women carrying BRCA2 gene mutations and nine women with BRCA1 mutations, with 10 healthy women that had no family history of breast cancer in a control group. All women underwent 2-D Localized Correlated Spectroscopy (L-COSY), and contrast enhanced 3-T MRI and ultrasound.
MRI or ultrasound scans did not show any abnormalities in the high-risk group, while L-COSY MRS found statistically significant biochemical changes in women with BRCA1 and BRCA2 gene mutations compared to controls.
Carolyn Mountford, MSc, D.Phil., from the University of Newcastle (Callaghan, Australia), said, “These changes appear to represent a series of early warning signs that may allow women to make informed decisions as to when and if they [should] have prophylactic mastectomy.”
Related Links:
University of Newcastle
The discovery was made in a study carried out by a multidisciplinary team, including radiologists, radiographers, an MR physicist, and chemists. The study was published online in the March issue of the journal Radiology.
The study compared 14 women carrying BRCA2 gene mutations and nine women with BRCA1 mutations, with 10 healthy women that had no family history of breast cancer in a control group. All women underwent 2-D Localized Correlated Spectroscopy (L-COSY), and contrast enhanced 3-T MRI and ultrasound.
MRI or ultrasound scans did not show any abnormalities in the high-risk group, while L-COSY MRS found statistically significant biochemical changes in women with BRCA1 and BRCA2 gene mutations compared to controls.
Carolyn Mountford, MSc, D.Phil., from the University of Newcastle (Callaghan, Australia), said, “These changes appear to represent a series of early warning signs that may allow women to make informed decisions as to when and if they [should] have prophylactic mastectomy.”
Related Links:
University of Newcastle
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer